ROCKVILLE, Md.--(BUSINESS WIRE)--BioReliance announced today that iNet™, the company’s new electronic sample submission and study tracking system that allows clients to track their test article submissions and review project status, has recently achieved a 66% utilization rate among all U.S. orders. iNet™ also allows clients to view final reports online and archives the reports electronically for the customer for two years. Introduced in early 2007 for clients submitting orders to BioReliance’s U.S. testing facilities, iNet will be expanded later this year to clients submitting orders to the company’s U.K. facilities.
